
41.59 BATS BZX Real-Time Price As of 3:12pm ET | ![]() Today’s Change | 21.57 Today|||52-Week Range 42.07 | +8.17% Year-to-Date |
PetIQ (PETQ) Surges 5.8%: Is This an Indication of Further Gains? 8:10am / Zacks.com - Paid Partner Content | PetIQ Stock Shows Every Sign Of Being Modestly Overvalued Apr 19 / GuruFocus News - Paid Partner Content |
Previous close | 39.14 |
Today’s open | 39.50 |
Day’s range | 39.27 - 42.07 |
Volume | 28,666 |
Average volume (3 months) | 296,586 |
Market cap | $1.1B |
Earnings growth (last year) | -522.15% |
Earnings growth (this year) | +104.14% |
Earnings growth (next 5 years) | +25.00% |
Revenue growth (last year) | +9.95% |
P/E ratio | NM |
Price/Sales | 1.21 |
Price/Book | 3.63 |
Today’s change | Today’s % change | |
---|---|---|
AFMDAffimed NV | -0.80 | -8.32% |
OMEROmeros Corp | +0.49 | +2.71% |
YMABY-mAbs Therapeutics ... | +0.41 | +1.61% |
OCULOcular Therapeutix I... | -0.40 | -2.63% |
Next reporting date | May 13, 2021 |
EPS forecast (this quarter) | $0.14 |
Annual revenue (last year) | $780.1M |
Annual profit (last year) | -$77.5M |
Net profit margin | -9.93% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Eagle, Idaho |